Back to Database
Status published
High
CVE-2018-14787
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or...
Vulnerability Description
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Impact Analysis
Refer to official advisory for detailed impact metrics.
Remediation
Ensure systems are updated to the latest vendor-supplied patch levels.
THREAT MONITOR
Am I Vulnerable?
Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2018-14787
Credits & Attribution
No credits recorded in the NVD database.
References
More from Philips
View All →CVE-2025-3426
Use of default hardcoded credentials
High
7.2
CVE-2025-3425
Unauthenticated Remote Code Execution via .NET Deserialization
High
7.3
CVE-2025-3424
3.2.1 Arbitrary File Read in insecure .NET Remoting TCP Channel
High
7.7
CVE-2025-2230
Philips Intellispace Cardiovascular (ISCV) Improper Authentication
High
8.5
CVE-2025-2229
Philips Intellispace Cardiovascular (ISCV) Use of Weak Credentials
High
8.5
Affected Vendor
Philips
View all reports →Affected Software
IntelliSpace Cardiovascular (ISCV) products
Vulnerable Versions:
IntelliSpace Cardiovascular, Version 3.1 or prior, Xcelera Version 4.1 or prior
Timeline
Official Publish:
August 22nd, 2018
Last Modified:
September 16th, 2024
Added to House:
July 20th, 2026
CVSS Vectors
V3:
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H